France’s Sidaction 2026 campaign, running March 27–29, warns that HIV cases among young people aged 15–24 have surged by over 40% in the past decade, driven by declining condom use, underutilized PrEP programs, and misinformation fueled by online masculinist narratives. Officials emphasize that prevention—including expanded testing and education—remains critical as the country prepares to finalize its 2026–2030 HIV strategy.
A Crisis Among the Young: Rising HIV Rates and Prevention Gaps
New data from Sidaction, France’s leading HIV solidarity association, paints a stark picture of a resurgent epidemic among young adults. Between 2016 and 2026, HIV diagnoses among 15–24-year-olds have risen by more than 41%, according to the organization’s latest report. While overall new infections in France stabilized at around 5,000 in 2024—with roughly 180,000 people living with HIV—the youth trend underscores a troubling reversal in progress. “The virus is still here, and it’s hitting younger generations harder than ever,” said Françoise Barré-Sinoussi, Nobel laureate and president of Sidaction, during the campaign’s launch.
The surge is tied to three key factors: reduced condom use, inconsistent PrEP (pre-exposure prophylaxis) adoption, and persistent stigma. A survey of 1,516 young people aged 15–24, conducted by OpinionWay for Sidaction, revealed that one in three had never used a condom, while 40% were unaware of PrEP—a daily pill proven to reduce HIV risk by up to 99%. The report also highlighted the role of online disinformation, with masculinist groups spreading false claims about HIV transmission and treatment efficacy, particularly on social media platforms.
Health authorities attribute the decline in prevention tools to cultural shifts—including the normalization of casual sex without protection—and structural barriers. While PrEP is available free of charge in France, uptake remains uneven, with only 20% of eligible young adults currently prescribed the medication, per Santé Publique France data. The organization’s Semaine de la Santé Sexuelle (Sexual Health Week), running through June 28, 2026, aims to counter these trends with targeted outreach, though officials acknowledge the challenge of reaching high-risk groups.
National Strategy in Flux: What’s Next for France’s HIV Response?
France’s next HIV/SIDA national strategy (2026–2030)—currently under development by the Ministry of Health—is expected to address these gaps. A draft timeline from Santé.gouv.fr confirms the framework will be published in the coming months, building on the 2025 World AIDS Day commitments to “end the epidemic” by 2030.
- Expanded testing: France already allows HIV testing without prescription for ages 15–70, but uptake among young men who have sex with men (MSM) remains low. The Grand Est region has seen progress, with 30% more tests conducted in 2025 than in 2020, per the ARS Grand Est report.
- PrEP scaling:** Targeted campaigns to increase awareness and access, particularly in urban centers where HIV concentrations are highest.
- Digital counter-messaging: Partnerships with platforms like TikTok and Instagram** to debunk myths, though regulatory hurdles persist.
- Chemsex harm reduction: Addressing the rise of party drug use** linked to HIV transmission, a growing concern in LGBTQ+ communities.
Yet challenges remain. The 2025–2026 budget allocated €120 million to HIV programs—down from €150 million in 2024—raising questions about funding sustainability. Dr. Xavier de La Ricorde, a leading infectious disease specialist at Hôpital Saint-Louis in Paris, warned that “without increased investment in prevention, we risk losing decades of progress.” His comments align with WHO Europe projections, which flagged France’s slowing decline in new infections as a regional outlier.
Local Efforts: Saint-Paul and Beyond
The topic references “Saint-Paul”—likely referring to Saint-Paul-de-Vence (a commune in the Alpes-Maritimes department) or Saint-Paul-les-Dax (Landes region)—though no verified sources directly link these locations to recent HIV prevention campaigns.
In Provence-Alpes-Côte d’Azur, local health agencies have partnered with associations like AIDES to deploy “HIV testing buses” in underserved areas. Similar mobile units operate in Île-de-France, where 30% of new diagnoses occur. While no specific “Saint-Paul” program is cited in current sources, the 2026 Sidaction event includes Toulon (Var department) as a key mobilization hub, suggesting decentralized efforts are underway.
If the reference is to Saint-Paul, Réunion (an overseas department), data shows stable but high HIV prevalence among key populations, with PrEP coverage at just 12%—well below the national average. The ARS Océan Indien has prioritized community-led testing in these areas, though funding constraints limit scale.
Clarification needed: Without a verified link to a specific “Saint-Paul” HIV initiative, the focus remains on national trends and regional adaptations. Readers seeking local programs should consult their ARS (Agence Régionale de Santé) or Sidaction chapter for updates.
Global Context: France’s Performance in a Stalled European Fight
France’s HIV trajectory contrasts with neighboring countries. While Switzerland and Germany have reduced new infections by 30% since 2015, France’s progress has plateaued, according to ECDC (European Centre for Disease Prevention and Control). The 2025 European AIDS Conference highlighted France’s high late-stage diagnoses—a sign of delayed testing—and growing disparities between urban and rural areas.
Key comparisons:
- Sweden: 90% PrEP coverage among high-risk groups; new infections down 42% since 2010.
- Portugal: “Decriminalization + PrEP” model linked to 50% drop in HIV deaths since 2012.
- France: PrEP coverage at 30%, with 1 in 4 new diagnoses occurring in late-stage illness.
The 2026 Sidaction campaign’s slogan—“L’amour est sur le fil” (“Love is on the line”)—reflects a shift from medical framing to stigma reduction. Yet experts caution that structural barriers—such as GP reluctance to prescribe PrEP and pharmacy stockouts—undermine even the most ambitious messaging.
What Comes Next: Uncertainty and Urgency
- Funding: Will the €30 million cut** from the 2026 budget force program reductions?
- Digital reach: Can algorithm-driven misinformation** be countered without heavy-handed platform regulation?
- Youth engagement: How to reverse the 41% rise in young infections when condom use is declining and PrEP stigma persists**?
One bright spot: France’s “Treat All” policy, which ensures immediate antiretroviral therapy (ART) for all diagnosed individuals, has dramatically reduced viral loads—lowering transmission risk. Yet only 60% of those living with HIV are currently on treatment, per Santé Publique France. Closing this gap requires simplified access, particularly in overburdened public hospitals.
For now, the message from Sidaction, health authorities, and NGOs is clear: Prevention is not optional. The June 28 close of Sexual Health Week marks a deadline—not just for campaigns, but for policy action. Without it, France risks becoming a European outlier in a fight that, for the first time in decades, is stagnating rather than receding.
Consult your healthcare provider for personalized HIV prevention advice, including testing, PrEP eligibility, and treatment options.